IDiyas

For the Inventor, By the Inventor

Emeryville, CA, United States of America

Youngsook Shin

USPTO Granted Patents = 23 


 

Average Co-Inventor Count = 9.3

ph-index = 8

Forward Citations = 305(Granted Patents)


Location History:

  • San Mateo, CA (US) (2007 - 2009)
  • Emeryville, CA (US) (2010 - 2018)
  • Thousand Oaks, CA (US) (2016 - 2024)

Company Filing History:

goldMedal23 out of 1,970 
 
Amgen Inc.
 patents
silverMedal1 out of 124 
 
Teijin Pharma Limited
 patents
where one patent can have more than one assignee

Years Active: 2007-2024

where 'Filed Patents' based on already Granted Patents

23 patents (USPTO):
1. 11905281 - KRAS G12C inhibitors and methods of using the same (2024-02-20),
2. 11766436 - KRAS G12C inhibitors and methods of using the same (2023-09-26),
3. 11285156 - Substituted piperazines as KRAS G12C inhibitors (2022-03-29),
4. 11090304 - KRAS G12C inhibitors and methods of using the same (2021-08-17),
5. 11053226 - KRAS G12C inhibitors and methods of using the same (2021-07-06),
6. 10519146 - KRAS G12C inhibitors and methods of using the same (2019-12-31),
7. 9873701 - Heterocyclic compounds and their uses (2018-01-23),
8. 9365522 - Pyrazole amide derivative (2016-06-14),
9. 8901135 - Heterocyclic compounds and their uses (2014-12-02),
10. 8765940 - Heterocyclic compounds and their uses (2014-07-01),
11. 8765768 - Heterocyclic compounds and their uses (2014-07-01),
12. 8754089 - Heterocyclic compounds and their uses (2014-06-17),
13. 8633313 - Heterocyclic compounds and their uses (2014-01-21),
14. 8586739 - Heterocyclic compounds and their uses (2013-11-19),
15. 8575183 - Heterocyclic compounds and their uses (2013-11-05),

Title: Youngsook Shin: A Pioneering Inventor in Cancer Treatment

Introduction

Youngsook Shin is an accomplished inventor based in Emeryville, California, recognized for his substantial contributions to the field of cancer research. With a remarkable portfolio of 23 patents, Shin has made significant strides in developing innovative treatments aimed at targeting specific cancer types, showcasing his expertise and commitment to advancing medical science.

Latest Patents

Among his latest innovations are the KRAS G12C inhibitors, which offer promising methods for treating various cancers, including pancreatic, colorectal, and lung cancers. These inhibitors are not only effective but also highlight the potential for targeted therapies in oncology. The patents detail compositions and methodologies that could revolutionize treatment regimens for patients suffering from these aggressive diseases.

Career Highlights

Throughout his career, Youngsook Shin has worked with prestigious organizations such as Amgen Inc. and Teijin Pharma Limited. His tenure at these companies has allowed him to collaborate with some of the brightest minds in the industry and to refine his inventions to better serve patient needs.

Collaborations

Shin has shared his innovative journey with talented colleagues like Timothy David Cushing and Xiaolin Hao. Their joint efforts have fostered an environment rich in creativity and problem-solving, further enhancing the development of groundbreaking therapies within their fields.

Conclusion

As a prominent inventor dedicated to cancer research, Youngsook Shin continues to make a profound impact on the medical community. His inventions, particularly the KRAS G12C inhibitors, pave the way for new treatment options, underscoring the importance of innovation in addressing complex health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…